Hype around obesity drugs may not mean gains for Indian
Aditya Khemka, Fund Manager at InCred Asset Management, remains cautious about Indian companies looking to manufacture GLP-1 products.
Source
<meta name="google-adsense-account" content="ca-pub-6363428395369086">
- This Is How Google Is Using AI to Combat Online
- Three reasons why India’s deep tech startups are hamstrung, as